Arif G. Akyildiz
Erzincan, 24000, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer.
Journal: Experimental hematology & oncology
Published: February 19, 2026
Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study.
Journal: Journal of clinical medicine
Published: January 17, 2026
Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: January 11, 2026
Comprehensive Review of Transarterial Chemoembolization Plus Systemic Therapy in Advanced Hepatocellular Carcinoma.
Journal: Journal of gastrointestinal cancer
Published: August 25, 2025
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: April 17, 2025
"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
Journal: Medicina (Kaunas, Lithuania)
Published: April 10, 2025
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey.
Journal: Journal of chemotherapy (Florence, Italy)
Published: November 26, 2024
The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional Study.
Journal: Integrative cancer therapies
Published: October 05, 2024
Prognostic and predictive significance of the pan-immune-inflammation value in endometrial cancer patients undergoing adjuvant therapy.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: September 03, 2024
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer.
Journal: Biomarkers in medicine
Published: August 13, 2024
Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer.
Journal: Japanese journal of clinical oncology
Published: July 24, 2024
Last Updated: 09/26/2026